US FDA approves AstraZeneca's drug for breast cancer
The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...
Medscape48m
FDA Approves New ADC for HR+, HER2- Breast Cancer
The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with ...
Inside Edition Reporter Undergoes Double Mastectomy After Discovering Breast Cancer on Assignment
Inside Edition' reporter Alison Hall undergoes a double mastectomy, after discovering her breast cancer while on assignment.
AstraZeneca Gets FDA Approval for Metastatic Breast Cancer Treatment Datroway
AstraZeneca said the U.S. Food and Drug Administration approved Datroway, a treatment for metastatic breast cancer developed in combination with Daiichi Sankyo.
Relay Therapeutics' SWOT analysis: stock poised for growth amid fierce competition
Relay Therapeutics (market cap: $748.2 million), a biotechnology company focused on developing innovative cancer therapies, ...
Science Daily8m
Multi-target approach counters tumor growth in several cancers
The tissue adjacent to a tumor behaves differently than areas farther away: The tumor's cancerous cells influence their surroundings, blocking the body's immune defenses and creating a sort of haven ...
WBOC47m
Study: Young Women Twice As Likely To Be Diagnosed With Cancer As Young Men
According to new data from the American Cancer Society, young women are diagnosed with cancer at twice the rate of young men, with breast and thyroid cancers dominating the trend.